Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable

Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable

Aggressive glioblastoma (GBM) has no known treatment as a primary brain tumor. Since the cancer is so heterogeneous, an immunosuppressive tumor microenvironment (TME) exists, and the blood–brain barrier (BBB) prevents chemotherapeutic chemicals from reaching the central nervous system (CNS), therape...

Full description

Bibliographic Details
Main Authors: Amir Barzegar Behrooz, Zahra Talaie, Amir Syahir
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
glioblastoma
nanotechnology
nanomedicine
nanocarriers
drug delivery
Online Access:https://www.mdpi.com/1999-4923/14/8/1697

Similar Items

Similar Items